NCT03429595 - Study Evaluating the Safety, Tolerability, PK, and Activity of Topical ATx201 Gel in Outpatients With Impetigo | Biotech Hunter

Enrollment

210

Participants

Timeline

Start Date

February 23, 2018

Primary Completion Date

June 26, 2018

Study Completion Date

June 26, 2018

Conditions

Impetigo

Interventions

DRUG

ATx201

ATx201 GEL

OTHER

ATx201 GEL Vehicle

Vehicle

Trial Locations (16)

AntibioTx Investigational Site, Bloemfontein

AntibioTx Investigative Site, Boksburg

AntibioTx Investigative Site, Claremont

AntibioTx Investigative Site, Durban

AntibioTx Investigative Site, eMkhomazi

AntibioTx Investigative Site, Germiston

AntibioTx Investigative Site 2, Johannesburg

AntibioTx Investigative Site, Johannesburg

AntibioTx Investigative Site, Kraaifontein

AntibioTx Investigative Site, Mpumalanga

AntibioTx Investigative Site, Paarl

AntibioTx Investigative Site 2, Port Elizabeth

AntibioTx Investigative Site, Port Elizabeth

AntibioTx Investigative Site, Pretoria

AntibioTx Investigative Site, Soshanguve

AntibioTx Investigative Site, Winnie Mandela